COLURACETAM

COLURACETAM Overview Nootropics are a brand new type of cognitive enhancing drug, they are not regulated in the US and most are still pending FDA approval. Nootropics also pose no notable side effects (unless stated otherwise) as long as proper dosage instructions are followed. Overview Coluracetam has a lot of characteristics in common with other […]

TIANEPTINE SULFATE

TIANEPTINE SULFATE NOTE: TIANEPTINE SULFATE IS A FASTER RELEASING VERSION OF TIANEPTINE WITH A LONGER HALF-LIFE. Nootropics are a brand new type of cognitive enhancing drug, they are not regulated in the US and most are still pending FDA approval. Nootropics also pose no notable side effects (unless stated otherwise) as long as proper dosage […]

ANIRACETAM

ANIRACETAM Nootropics are a brand new type of cognitive enhancing drug, they are not regulated in the US and most are still pending FDA approval. Nootropics also pose no notable side effects (unless stated otherwise) as long as proper dosage instructions are followed. Overview Aniracetam works to improve mental capability. It boosts memory retention and […]

ALPHA-GPC

ALPHA-GPC Nootropics are a brand new type of cognitive enhancing drug, they are not regulated in the US and most are still pending FDA approval. Nootropics also pose no notable side effects (unless stated otherwise) as long as proper dosage instructions are followed. Overview Alpha GPC is phospholipid, and this directly impacts development of cell […]

CITICOLINE/CDP CHOLINE SODIUM

CITICOLINE/CDP CHOLINE SODIUM Nootropics are a brand new type of cognitive enhancing drug, they are not regulated in the US and most are still pending FDA approval. Nootropics also pose no notable side effects (unless stated otherwise) as long as proper dosage instructions are followed. Overview Citicoline (CDP Choline, cytidine diphosphate-choline) is one of the […]

Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Stay up to date with all the latest offers and updates from Sarms Central
ErrorHere